Optomed is a Finnish medical technology company and a leading provider of handheld fundus cameras. Optomed combines handheld fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye diseases such as rapidly increasing diabetic retinopathy.
Optomed was founded in Oulu, Finland in 2004 by Seppo Kopsala Optomed’s CEO, with the vision to design and produce a smaller and more affordable fundus camera than traditionally used desktop cameras, which would improve the efficiency of the eye screening of diabetics. In the early years, the operations were focused on research and development with a long-term perspective and sales activities were limited.
Worldwide
HeadquartersYrttipellontie 1, 90230 Oulu – Finland
Line item in (eur) | 01.01.2019 | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|---|---|
Assets | N/A | 39,611,000.00 | 31,073,000.00 | 28,998,000.00 | 31,300,000.00 |
Noncurrent Assets | N/A | 14,151,000.00 | 14,289,000.00 | 14,626,000.00 | 15,210,000.00 |
Property Plant And Equipment | N/A | 406,000.00 | 359,000.00 | 433,000.00 | 852,000.00 |
Goodwill | N/A | 4,256,000.00 | 4,256,000.00 | 4,256,000.00 | 4,256,000.00 |
Intangible Assets Under Development | N/A | 5,218,000.00 | 5,667,000.00 | 6,338,000.00 | 6,562,000.00 |
Other Intangible Assets | N/A | 519,000.00 | 485,000.00 | 358,000.00 | 379,000.00 |
Deferred Tax Assets | N/A | 8,000.00 | 11,000.00 | 13,000.00 | 15,000.00 |
Current Assets | N/A | 25,459,000.00 | 16,784,000.00 | 14,371,000.00 | 16,090,000.00 |
Inventories | N/A | 2,468,000.00 | 2,539,000.00 | 2,936,000.00 | 2,998,000.00 |
Current Trade Receivables | N/A | 2,897,000.00 | 2,639,000.00 | 3,658,000.00 | 3,556,000.00 |
Other Current Receivables | N/A | 1,228,000.00 | 998,000.00 | 973,000.00 | 1,012,000.00 |
Cash and cash equivalents | 2,000,000.00 | 18,866,000.00 | 10,608,000.00 | 6,804,000.00 | 8,524,000.00 |
Equity And Liabilities | N/A | 39,611,000.00 | 31,073,000.00 | 28,998,000.00 | 31,300,000.00 |
Equity | 5,552,000.00 | 22,637,000.00 | 20,073,000.00 | 17,052,000.00 | 20,342,000.00 |
Issued Capital | N/A | 80,000.00 | 80,000.00 | 80,000.00 | 80,000.00 |
Retained Earnings Profit Loss For Reporting Period | N/A | N/A | N/A | -4,249,000.00 | -5,472,000.00 |
Retained Earnings Excluding Profit Loss For Reporting Period | N/A | N/A | N/A | -17,721,000.00 | -21,717,000.00 |
Share Premium | N/A | 504,000.00 | 504,000.00 | 504,000.00 | 504,000.00 |
Liabilities | N/A | 16,973,000.00 | 11,001,000.00 | 11,946,000.00 | 10,957,000.00 |
Noncurrent Liabilities | N/A | 9,416,000.00 | 7,512,000.00 | 7,034,000.00 | 5,731,000.00 |
Deferred Tax Liabilities | N/A | 616,000.00 | 540,000.00 | 463,000.00 | 387,000.00 |
Longterm Borrowings | N/A | 5,104,000.00 | 3,520,000.00 | 3,813,000.00 | 3,380,000.00 |
Current Liabilities | N/A | 7,557,000.00 | 3,489,000.00 | 4,912,000.00 | 5,227,000.00 |
Trade And Other Current Payables To Trade Suppliers | N/A | 1,667,000.00 | 595,000.00 | 944,000.00 | 869,000.00 |
Other Current Payables | N/A | 3,650,000.00 | 2,141,000.00 | 2,308,000.00 | 2,959,000.00 |
Line item in (eur) | 01.01.2019/ 01.01.2020 |
01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
---|---|---|---|---|
Revenue | 14,977,000.00 | 13,011,000.00 | 14,850,000.00 | 14,660,000.00 |
Other Income | 254,000.00 | 157,000.00 | 810,000.00 | 857,000.00 |
Employee Benefits Expense | 7,299,000.00 | 7,319,000.00 | 8,702,000.00 | 8,827,000.00 |
Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 2,261,000.00 | 2,173,000.00 | 2,778,000.00 | 3,145,000.00 |
Other Expense By Nature | 2,980,000.00 | 2,369,000.00 | 3,858,000.00 | 3,193,000.00 |
Profit Loss From Operating Activities | -2,596,000.00 | -2,906,000.00 | -4,780,000.00 | -5,097,000.00 |
Finance Income | 8,000.00 | 452,000.00 | 715,000.00 | 569,000.00 |
Finance Costs | 365,000.00 | 794,000.00 | 263,000.00 | 1,024,000.00 |
Profit Loss Before Tax | -2,952,000.00 | -3,247,000.00 | -4,327,000.00 | -5,551,000.00 |
Income Tax Expense Continuing Operations | -77,000.00 | -70,000.00 | -78,000.00 | -79,000.00 |
Profit (loss) | -2,875,000.00 | -3,177,000.00 | -4,249,000.00 | -5,472,000.00 |
Profit Loss Attributable To Owners Of Parent | -2,875,000.00 | -3,177,000.00 | -4,249,000.00 | -5,472,000.00 |
Line item in (eur) | 01.01.2019 | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|---|---|
Profit (loss) | N/A | -2,875,000.00 | -3,177,000.00 | -4,249,000.00 | -5,472,000.00 |
Adjustments For Decrease Increase In Inventories | N/A | -1,346,000.00 | -83,000.00 | -340,000.00 | -68,000.00 |
Adjustments For Depreciation And Amortisation Expense | N/A | 2,261,000.00 | 2,173,000.00 | N/A | N/A |
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | N/A | N/A | 2,173,000.00 | 2,689,000.00 | 3,145,000.00 |
Other Adjustments For Noncash Items | N/A | 466,000.00 | 284,000.00 | 454,000.00 | -770,000.00 |
Cash Flows From Used In Operations | N/A | 475,000.00 | -2,367,000.00 | -2,811,000.00 | -2,171,000.00 |
Interest Paid Classified As Operating Activities | N/A | 202,000.00 | 75,000.00 | 66,000.00 | 76,000.00 |
Interest Received Classified As Operating Activities | N/A | 24,000.00 | 366,000.00 | 1,000.00 | 0.00 |
Cash Flows From Used In Operating Activities | N/A | 161,000.00 | -2,801,000.00 | -2,940,000.00 | -2,370,000.00 |
Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 260,000.00 | 268,000.00 | 462,000.00 | 780,000.00 |
Purchase Of Intangible Assets Classified As Investing Activities | N/A | 1,175,000.00 | 1,553,000.00 | 2,112,000.00 | 2,249,000.00 |
Cash Flows From Used In Investing Activities | N/A | -1,434,000.00 | -1,820,000.00 | -2,574,000.00 | -3,029,000.00 |
Proceeds From Issuing Shares | N/A | 23,000,000.00 | 92,000.00 | 1,012,000.00 | 9,012,000.00 |
Proceeds From Borrowings Classified As Financing Activities | N/A | 176,000.00 | -167,000.00 | 1,366,000.00 | 0.00 |
Repayments Of Borrowings Classified As Financing Activities | N/A | 460,000.00 | 3,233,000.00 | 327,000.00 | 912,000.00 |
Payments Of Lease Liabilities Classified As Financing Activities | N/A | 385,000.00 | 390,000.00 | 414,000.00 | 415,000.00 |
Cash Flows From Used In Financing Activities | N/A | 18,123,000.00 | -3,698,000.00 | 1,637,000.00 | 7,003,000.00 |
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 16,849,000.00 | -8,319,000.00 | -3,876,000.00 | 1,605,000.00 |
Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | 17,000.00 | 61,000.00 | 73,000.00 | 115,000.00 |
Cash and cash equivalents | 2,000,000.00 | 18,866,000.00 | 10,608,000.00 | 6,804,000.00 | 8,524,000.00 |
Please note that some sums might not add up.
FI4000410881
LEI7437009IVYWGEE4S7B77
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.